Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort
Purpose To identify adherence to follow-up recommendations in long-term breast cancer survivors (LTBCS) of the SURBCAN cohort and to identify its determinants, using real-world data. Methods We conducted a retrospective study using electronic health records from 2012 to 2016 of women diagnosed with...
Gespeichert in:
| Veröffentlicht in: | Breast cancer research and treatment 2022-06, Vol.193 (2), p.455-465 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 465 |
|---|---|
| container_issue | 2 |
| container_start_page | 455 |
| container_title | Breast cancer research and treatment |
| container_volume | 193 |
| creator | Santiá, Paula Jansana, Anna del Cura, Isabel Padilla-Ruiz, Maria Domingo, Laia Louro, Javier Comas, Mercè Sanz, Teresa Duarte-Salles, Talita Redondo, Maximino Ibañez, Berta Prados-Torres, Alexandra Castells, Xavier Sala, Maria |
| description | Purpose
To identify adherence to follow-up recommendations in long-term breast cancer survivors (LTBCS) of the SURBCAN cohort and to identify its determinants, using real-world data.
Methods
We conducted a retrospective study using electronic health records from 2012 to 2016 of women diagnosed with incident breast cancer in Spain between 2000 and 2006 and surviving at least 5 years. Adherence to basic follow-up recommendations, adherence according to risk of recurrence, and overall adherence were calculated based on attendance at medical appointments and imaging surveillance, by year of survivorship. Logistic regression models were fitted to depict the association between adherence and its determinants.
Results
A total of 2079 LTBCS were followed up for a median of 4.97 years. Of them, 23.6% had survived ≥ 10 years at baseline. We estimated that 79.5% of LTBCS were overall adherent to at least one visit and one imaging test. Adherence to recommendations decreased over time and no differences were found according to recurrence risk. Determinants of better overall adherence were diagnosis in middle age (50–69 years old), living in a more-deprived area, having fewer years of survival, receiving primary treatment, and being alive at the end of follow-up.
Conclusion
We identified women apparently not complying with surveillance visits and tests. Special attention should be paid to the youngest and eldest women at diagnosis and to those with longer survival. |
| doi_str_mv | 10.1007/s10549-022-06563-x |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9090857</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A703236411</galeid><sourcerecordid>A703236411</sourcerecordid><originalsourceid>FETCH-LOGICAL-c572t-ab6634decef73a419a5c2a6105f7c76a46dcd0b1a6200cc12054ccf377ac9fce3</originalsourceid><addsrcrecordid>eNp9kl9rFDEUxYModl39Aj5IQBBfUpPMTLLjg7Au_oOioPY5ZDN3dlIyyZpktu0H8HuburXtikgeBnJ-54R75yD0lNFjRql8lRht6pZQzgkVjajIxT00Y42siORM3kczyoQkYkHFEXqU0hmltJW0fYiOqoa3xVvP0M9lN0AEbwCHHrvgNyRDHPE6gk4ZG12UiNMUd3YXYsI54D44F87JtC1qBLyZbAfOekivscYpT90lXusEHQ4elxRHzkN0He501riPYcR5APzt9Ovb1fIzNmEIMT9GD3rtEjy5_s7R6ft331cfycmXD59WyxNiGskz0WshqroDA72sdM1a3RiuRVlDL40Uuhad6eiaacEpNYbxMqMxfSWlNm1voJqjN_vc7bQeoTPgc9RObaMddbxUQVt1qHg7qE3YqZa2dFE2O0cvrwNi-DFBymq0yYBz2kOYkuKiprReNE1b0Od_oWdhir6MVyjBJOdNLW6pjXagrO9DeddchaqlpBWvRM1YoY7_QZXTwWhN8NDbcn9geHHHMJS_kIcU3JRt8OkQ5HvQxJBShP5mGYyqq5apfctUaZn63TJ1UUzP7q7xxvKnVgWo9kAqkt9AvJ39P7G_AGdA3ac</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2661722546</pqid></control><display><type>article</type><title>Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort</title><source>SpringerLink Journals - AutoHoldings</source><creator>Santiá, Paula ; Jansana, Anna ; del Cura, Isabel ; Padilla-Ruiz, Maria ; Domingo, Laia ; Louro, Javier ; Comas, Mercè ; Sanz, Teresa ; Duarte-Salles, Talita ; Redondo, Maximino ; Ibañez, Berta ; Prados-Torres, Alexandra ; Castells, Xavier ; Sala, Maria</creator><creatorcontrib>Santiá, Paula ; Jansana, Anna ; del Cura, Isabel ; Padilla-Ruiz, Maria ; Domingo, Laia ; Louro, Javier ; Comas, Mercè ; Sanz, Teresa ; Duarte-Salles, Talita ; Redondo, Maximino ; Ibañez, Berta ; Prados-Torres, Alexandra ; Castells, Xavier ; Sala, Maria ; SURBCAN Group ; SURBCAN Group</creatorcontrib><description>Purpose
To identify adherence to follow-up recommendations in long-term breast cancer survivors (LTBCS) of the SURBCAN cohort and to identify its determinants, using real-world data.
Methods
We conducted a retrospective study using electronic health records from 2012 to 2016 of women diagnosed with incident breast cancer in Spain between 2000 and 2006 and surviving at least 5 years. Adherence to basic follow-up recommendations, adherence according to risk of recurrence, and overall adherence were calculated based on attendance at medical appointments and imaging surveillance, by year of survivorship. Logistic regression models were fitted to depict the association between adherence and its determinants.
Results
A total of 2079 LTBCS were followed up for a median of 4.97 years. Of them, 23.6% had survived ≥ 10 years at baseline. We estimated that 79.5% of LTBCS were overall adherent to at least one visit and one imaging test. Adherence to recommendations decreased over time and no differences were found according to recurrence risk. Determinants of better overall adherence were diagnosis in middle age (50–69 years old), living in a more-deprived area, having fewer years of survival, receiving primary treatment, and being alive at the end of follow-up.
Conclusion
We identified women apparently not complying with surveillance visits and tests. Special attention should be paid to the youngest and eldest women at diagnosis and to those with longer survival.</description><identifier>ISSN: 0167-6806</identifier><identifier>EISSN: 1573-7217</identifier><identifier>DOI: 10.1007/s10549-022-06563-x</identifier><identifier>PMID: 35290544</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Breast cancer ; Cancer ; Cancer research ; Cancer survivors ; Diagnosis ; Electronic medical records ; Electronic records ; Epidemiology ; Health surveillance ; Medical records ; Medicine ; Medicine & Public Health ; Oncology ; Oncology, Experimental ; Practice guidelines (Medicine) ; Regression analysis ; Survival</subject><ispartof>Breast cancer research and treatment, 2022-06, Vol.193 (2), p.455-465</ispartof><rights>The Author(s) 2022</rights><rights>2022. The Author(s).</rights><rights>COPYRIGHT 2022 Springer</rights><rights>The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c572t-ab6634decef73a419a5c2a6105f7c76a46dcd0b1a6200cc12054ccf377ac9fce3</citedby><cites>FETCH-LOGICAL-c572t-ab6634decef73a419a5c2a6105f7c76a46dcd0b1a6200cc12054ccf377ac9fce3</cites><orcidid>0000-0002-9955-8746</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10549-022-06563-x$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10549-022-06563-x$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35290544$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Santiá, Paula</creatorcontrib><creatorcontrib>Jansana, Anna</creatorcontrib><creatorcontrib>del Cura, Isabel</creatorcontrib><creatorcontrib>Padilla-Ruiz, Maria</creatorcontrib><creatorcontrib>Domingo, Laia</creatorcontrib><creatorcontrib>Louro, Javier</creatorcontrib><creatorcontrib>Comas, Mercè</creatorcontrib><creatorcontrib>Sanz, Teresa</creatorcontrib><creatorcontrib>Duarte-Salles, Talita</creatorcontrib><creatorcontrib>Redondo, Maximino</creatorcontrib><creatorcontrib>Ibañez, Berta</creatorcontrib><creatorcontrib>Prados-Torres, Alexandra</creatorcontrib><creatorcontrib>Castells, Xavier</creatorcontrib><creatorcontrib>Sala, Maria</creatorcontrib><creatorcontrib>SURBCAN Group</creatorcontrib><creatorcontrib>SURBCAN Group</creatorcontrib><title>Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort</title><title>Breast cancer research and treatment</title><addtitle>Breast Cancer Res Treat</addtitle><addtitle>Breast Cancer Res Treat</addtitle><description>Purpose
To identify adherence to follow-up recommendations in long-term breast cancer survivors (LTBCS) of the SURBCAN cohort and to identify its determinants, using real-world data.
Methods
We conducted a retrospective study using electronic health records from 2012 to 2016 of women diagnosed with incident breast cancer in Spain between 2000 and 2006 and surviving at least 5 years. Adherence to basic follow-up recommendations, adherence according to risk of recurrence, and overall adherence were calculated based on attendance at medical appointments and imaging surveillance, by year of survivorship. Logistic regression models were fitted to depict the association between adherence and its determinants.
Results
A total of 2079 LTBCS were followed up for a median of 4.97 years. Of them, 23.6% had survived ≥ 10 years at baseline. We estimated that 79.5% of LTBCS were overall adherent to at least one visit and one imaging test. Adherence to recommendations decreased over time and no differences were found according to recurrence risk. Determinants of better overall adherence were diagnosis in middle age (50–69 years old), living in a more-deprived area, having fewer years of survival, receiving primary treatment, and being alive at the end of follow-up.
Conclusion
We identified women apparently not complying with surveillance visits and tests. Special attention should be paid to the youngest and eldest women at diagnosis and to those with longer survival.</description><subject>Breast cancer</subject><subject>Cancer</subject><subject>Cancer research</subject><subject>Cancer survivors</subject><subject>Diagnosis</subject><subject>Electronic medical records</subject><subject>Electronic records</subject><subject>Epidemiology</subject><subject>Health surveillance</subject><subject>Medical records</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Oncology, Experimental</subject><subject>Practice guidelines (Medicine)</subject><subject>Regression analysis</subject><subject>Survival</subject><issn>0167-6806</issn><issn>1573-7217</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kl9rFDEUxYModl39Aj5IQBBfUpPMTLLjg7Au_oOioPY5ZDN3dlIyyZpktu0H8HuburXtikgeBnJ-54R75yD0lNFjRql8lRht6pZQzgkVjajIxT00Y42siORM3kczyoQkYkHFEXqU0hmltJW0fYiOqoa3xVvP0M9lN0AEbwCHHrvgNyRDHPE6gk4ZG12UiNMUd3YXYsI54D44F87JtC1qBLyZbAfOekivscYpT90lXusEHQ4elxRHzkN0He501riPYcR5APzt9Ovb1fIzNmEIMT9GD3rtEjy5_s7R6ft331cfycmXD59WyxNiGskz0WshqroDA72sdM1a3RiuRVlDL40Uuhad6eiaacEpNYbxMqMxfSWlNm1voJqjN_vc7bQeoTPgc9RObaMddbxUQVt1qHg7qE3YqZa2dFE2O0cvrwNi-DFBymq0yYBz2kOYkuKiprReNE1b0Od_oWdhir6MVyjBJOdNLW6pjXagrO9DeddchaqlpBWvRM1YoY7_QZXTwWhN8NDbcn9geHHHMJS_kIcU3JRt8OkQ5HvQxJBShP5mGYyqq5apfctUaZn63TJ1UUzP7q7xxvKnVgWo9kAqkt9AvJ39P7G_AGdA3ac</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>Santiá, Paula</creator><creator>Jansana, Anna</creator><creator>del Cura, Isabel</creator><creator>Padilla-Ruiz, Maria</creator><creator>Domingo, Laia</creator><creator>Louro, Javier</creator><creator>Comas, Mercè</creator><creator>Sanz, Teresa</creator><creator>Duarte-Salles, Talita</creator><creator>Redondo, Maximino</creator><creator>Ibañez, Berta</creator><creator>Prados-Torres, Alexandra</creator><creator>Castells, Xavier</creator><creator>Sala, Maria</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9955-8746</orcidid></search><sort><creationdate>20220601</creationdate><title>Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort</title><author>Santiá, Paula ; Jansana, Anna ; del Cura, Isabel ; Padilla-Ruiz, Maria ; Domingo, Laia ; Louro, Javier ; Comas, Mercè ; Sanz, Teresa ; Duarte-Salles, Talita ; Redondo, Maximino ; Ibañez, Berta ; Prados-Torres, Alexandra ; Castells, Xavier ; Sala, Maria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c572t-ab6634decef73a419a5c2a6105f7c76a46dcd0b1a6200cc12054ccf377ac9fce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Breast cancer</topic><topic>Cancer</topic><topic>Cancer research</topic><topic>Cancer survivors</topic><topic>Diagnosis</topic><topic>Electronic medical records</topic><topic>Electronic records</topic><topic>Epidemiology</topic><topic>Health surveillance</topic><topic>Medical records</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Oncology, Experimental</topic><topic>Practice guidelines (Medicine)</topic><topic>Regression analysis</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Santiá, Paula</creatorcontrib><creatorcontrib>Jansana, Anna</creatorcontrib><creatorcontrib>del Cura, Isabel</creatorcontrib><creatorcontrib>Padilla-Ruiz, Maria</creatorcontrib><creatorcontrib>Domingo, Laia</creatorcontrib><creatorcontrib>Louro, Javier</creatorcontrib><creatorcontrib>Comas, Mercè</creatorcontrib><creatorcontrib>Sanz, Teresa</creatorcontrib><creatorcontrib>Duarte-Salles, Talita</creatorcontrib><creatorcontrib>Redondo, Maximino</creatorcontrib><creatorcontrib>Ibañez, Berta</creatorcontrib><creatorcontrib>Prados-Torres, Alexandra</creatorcontrib><creatorcontrib>Castells, Xavier</creatorcontrib><creatorcontrib>Sala, Maria</creatorcontrib><creatorcontrib>SURBCAN Group</creatorcontrib><creatorcontrib>SURBCAN Group</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Breast cancer research and treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Santiá, Paula</au><au>Jansana, Anna</au><au>del Cura, Isabel</au><au>Padilla-Ruiz, Maria</au><au>Domingo, Laia</au><au>Louro, Javier</au><au>Comas, Mercè</au><au>Sanz, Teresa</au><au>Duarte-Salles, Talita</au><au>Redondo, Maximino</au><au>Ibañez, Berta</au><au>Prados-Torres, Alexandra</au><au>Castells, Xavier</au><au>Sala, Maria</au><aucorp>SURBCAN Group</aucorp><aucorp>SURBCAN Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort</atitle><jtitle>Breast cancer research and treatment</jtitle><stitle>Breast Cancer Res Treat</stitle><addtitle>Breast Cancer Res Treat</addtitle><date>2022-06-01</date><risdate>2022</risdate><volume>193</volume><issue>2</issue><spage>455</spage><epage>465</epage><pages>455-465</pages><issn>0167-6806</issn><eissn>1573-7217</eissn><abstract>Purpose
To identify adherence to follow-up recommendations in long-term breast cancer survivors (LTBCS) of the SURBCAN cohort and to identify its determinants, using real-world data.
Methods
We conducted a retrospective study using electronic health records from 2012 to 2016 of women diagnosed with incident breast cancer in Spain between 2000 and 2006 and surviving at least 5 years. Adherence to basic follow-up recommendations, adherence according to risk of recurrence, and overall adherence were calculated based on attendance at medical appointments and imaging surveillance, by year of survivorship. Logistic regression models were fitted to depict the association between adherence and its determinants.
Results
A total of 2079 LTBCS were followed up for a median of 4.97 years. Of them, 23.6% had survived ≥ 10 years at baseline. We estimated that 79.5% of LTBCS were overall adherent to at least one visit and one imaging test. Adherence to recommendations decreased over time and no differences were found according to recurrence risk. Determinants of better overall adherence were diagnosis in middle age (50–69 years old), living in a more-deprived area, having fewer years of survival, receiving primary treatment, and being alive at the end of follow-up.
Conclusion
We identified women apparently not complying with surveillance visits and tests. Special attention should be paid to the youngest and eldest women at diagnosis and to those with longer survival.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>35290544</pmid><doi>10.1007/s10549-022-06563-x</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-9955-8746</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-6806 |
| ispartof | Breast cancer research and treatment, 2022-06, Vol.193 (2), p.455-465 |
| issn | 0167-6806 1573-7217 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9090857 |
| source | SpringerLink Journals - AutoHoldings |
| subjects | Breast cancer Cancer Cancer research Cancer survivors Diagnosis Electronic medical records Electronic records Epidemiology Health surveillance Medical records Medicine Medicine & Public Health Oncology Oncology, Experimental Practice guidelines (Medicine) Regression analysis Survival |
| title | Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T14%3A30%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adherence%20of%20long-term%20breast%20cancer%20survivors%20to%20follow-up%20care%20guidelines:%20a%20study%20based%20on%20real-world%20data%20from%20the%20SURBCAN%20cohort&rft.jtitle=Breast%20cancer%20research%20and%20treatment&rft.au=Santi%C3%A1,%20Paula&rft.aucorp=SURBCAN%20Group&rft.date=2022-06-01&rft.volume=193&rft.issue=2&rft.spage=455&rft.epage=465&rft.pages=455-465&rft.issn=0167-6806&rft.eissn=1573-7217&rft_id=info:doi/10.1007/s10549-022-06563-x&rft_dat=%3Cgale_pubme%3EA703236411%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2661722546&rft_id=info:pmid/35290544&rft_galeid=A703236411&rfr_iscdi=true |